MiettinenO.S.The modern scientific physician: 5. the useful property of an intervention.CMAJ2001; 165: 1059–60.
2.
AltmanD.G., SchulzK.F., MoherD..; for the CONSORT Group. The revised CONSORT statement for reporting randomized trials: explanation and elaboration.Ann Intern Med2001; 134: 663–94.
3.
GrossC.P., MalloryR., HeiatA.. Reporting the recruitment process in clinical trials: who are these patients and how did they get there?Ann Intern Med2002; 137: 10–6.
4.
LaerumE., and LarsenS.Thiazide prophylaxis of urolithiasis. A double-blind study in general practice.Acta Med Scand1984; 215: 383–9.
5.
BorghiL., MeschiT., GuerraA.. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences.J Cardiovasc Pharm1993; 22(suppl): S78–S86.
6.
EttingerB., CitronJ.T., LivermoreB.. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not.J Urol1988; 139: 679–84.
7.
OhkawaM., TokunagaS., NakashimaT.. Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria.Br J Urol1992; 69: 571–6.
8.
BarceloP., WuhlO., ServitgeE.. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis.J Urol1993; 150: 1761–4.
9.
BorghiL., SchianchiT., MeschiT.. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria.N Engl J Med2002; 346: 77–84.
10.
EttingerB., CitronJ.T., TangA.. Prophylaxis of calcium oxalate stones: clinical trials of allopurinol, magnesium hydroxide and chlorthalidone In: Urolithiasis and Related Clinical Research. Ed. Schwille. Plenum Press, 1985; 549–52.
11.
EttingerB., TangA., CitronJ.T.. Randomized trial of allopurinol in the prevention of calcium oxalate calculi.N Engl J Med1986; 315: 1386–9.
12.
GoldfarbD.S., ModersitzkiF., AsplinJ.R.A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria.Clin J Am Soc Nephrol2007; 2: 745–9.
13.
LachinJ.M.Introduction to sample size determination and power analysis for clinical trials.Control Clin Trials1981; 2: 93–113.
14.
BorghiL., MeschiT., AmatoF.. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.J Urol1996; 155: 839–43.
15.
EttingerB., PakC.Y., CitronJ.T.. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis.J Urol1997; 158: 2069–73.
16.
KohriK., KodamaM., KatayamaY.. Allopurinol and thiazide effects on new urinary stone formed after discontinued therapy in patients with urinary stones.Urology1990; 36: 309–14.
17.
RobertsonW.G., PeacockM., SelbyP.L.. A multicentre trial to evaluate three treatments for recurrent idiopathic calcium stone disease – a preliminary report Robertson WG. In: Urolithiasis and Related Clinical Research. Ed. Schwille. Plenum Press, 1985; 545–8.
18.
ScottN.W., McPhersonG.C., RamsayC.R.. The method of minimization for allocation to clinical trials: a review.Control Clin Trials2002; 23: 662–74.
19.
ZerwekhJ.E., OdvinaC.V., WuermserL.A.. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.J Urol2007; 177: 2179–84.
20.
StraussA.L., CoeF.L., DeutschL.. Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study.Am J Med1982; 72: 17–24.
21.
LagakosS.W.The challenge of subgroup analyses - reporting without distorting.N Engl J Med2006; 354: 16.
DomrongkitchaipornS., SopassathitW., StitchantrakulW.. Schedule of taking calcium supplement and the risk of nephrolithiasis.Kidney Int2004; 65: 1835–41.
24.
HellerH.J., DoernerM.F., BrinkleyL.J., Adams-HuetB., PakC.Y.Effect of dietary calcium on stone forming propensity.J Urol2003; 169(2La nefrolitiasi nel terzo millennio: una patologia di pe): 470–4.
25.
MasseyL.K., LiebmanM., Kynast-GalesS.A.Ascorbate increases human oxaluria and kidney stone risk.J Nutr2005; 135: 1673–7.
26.
McHargT., RodgersA., CharltonK.Influence of cranberry juice on the urinary risk factors for calcium oxalate kidney stone formation.BJU Int2003; 92: 765–8.
27.
OdvinaC.V.Comparative value of orange juice versus lemonade in reducing stone-forming risk.Clin J Am Soc Nephrol2006; 1: 1269–74.
28.
FleissJ.L.Factorial experiments. In: The design and analysis of clinical experiments.New York: John Wiley and Sons, 1986.
